Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Commun Stat Simul Comput. 2014 Sep 11;45(8):3036–3052. doi: 10.1080/03610918.2014.911901

Table 5.

Data of example 2: proportion of patients with preventable adverse drug reactions (PADRs)

Study n(visits) n(PADRs)
1 10587 8
2 150 14
3 956 10
4 253 17
5 240 21
6 671 24
7 915 42
8 844 28
9 18820 880
10 6899 158
11 548 30
12 1756 78
13 1101 25
14 1802 28
15 2238 35
16 1017 19